1. Chen ST, Dou J, Temple R, Agarwal R, Wu KM, Walker S. New therapies from old medicines. Nat Biotechnol. 2008;26(10):1077–83.
2. FDA Guidance for Industry. Botanical drug development.
https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM458484.pdf
. Accessed on 17 April 2018.
3. Approved Labeling for Veregen (NDA 021902).
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2006/021902s000_prntlbl.pdf
. Accessed on 6 May 2018.
4. Approved Labeling for Fulyzaq (NDA 202292).
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/202292Orig1s000Lbl.pdf
. Accessed on 6 May 2018.
5. Drugs@FDA FDA: Veregen (NDA 021902).
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2006/021902s000TOC.cfm
. Accessed on 6 May 2018.